Pros | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Beats FD returns for both 3Y & 5Y duration. | |||
Cons | - |
INDMoney rank | - | |||
Category | Equity,Mid-Cap | |||
Fund Age | 8 Years | |||
Fund AUM | ₹4260 Cr | |||
Min Investment | SIP ₹500 Lumpsum ₹1000 | |||
Expense Ratio | 0.45% | |||
Exit Load | 1% | |||
Benchmark Index | Nifty Midcap 150 TR INR |
No of Holdings | 66 | |||
Top 5 Holdings | Indian Bank (3.05%) Glenmark Pharmaceuticals Ltd (3%) Max Financial Services Ltd (2.69%) The Federal Bank Ltd (2.52%) UNO Minda Ltd (2.44%) | |||
No of Sectors | 11 | |||
Top 3 Sectors | Financial Services (26.5%) Industrial (20.02%) Health (12.98%) | |||
Equity % | 97.44% | |||
Debt % | - | |||
P/E | 28.12 | |||
P/B | 3.65 | |||
Credit Quality | - | |||
Modified Duration | - | |||
YTM | - |
1-Month Return | 0.39% | |||
3-Month Return | 2.4% | |||
6-Month Return | 3.11% | |||
1-Year Return | 2.36% | |||
3-Year Return | 27.65% | |||
5-Year Return | 25.76% |
Sharpe | 1.14 | |||
Alpha | 2.11 | |||
Beta | 0.96 | |||
Standard Deviation | 15.39 | |||
Information Ratio | 0.6 |
Description | Mahindra Manulife Mid Cap Fund is an equity fund.The fund could potentially beat inflation in the long-run. | |||
Managers | Krishna Sanghavi,Kirti Dalvi,Manish Lodha |